Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
NCT Number: NCT03190070
Single arm physiological study to measure renal functional reserve as a biomarker of kidney function and health
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
The investigators will measure glomerular filtration rate using urinary clearance of cold iothalamate before and after an oral protein load in patients with chronic kidney disease and healthy volunteers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oral protein load as a physiological stimulus to temporarily increase glomerular filtration rate
Other names: Liquacel (Global Health Products, Rochester, NY)
Time frame: Single full-day clinic visit: Repeated glomerular filtration rate measurements are to be performed over the course of the day at a single study visit for each participant.
Short term-changes in the glomerular filtration rate will be measured before and after ingestion of oral protein
Brigham and Women's Hospital
Other
Measurement of Renal Functional Reserve With Urinary Clearance of Cold Iothalamate Before and After an Oral Protein Load
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07713524
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cairo, KasrAlainy, Egypt
View Trial DetailsNCT05434325
Autoimmune Diseases, Chronic Disease
Concord W., New South Wales, Australia
View Trial DetailsNCT07646015
Diabetes Mellitus, Diabetes Mellitus, Type 2
Mysore, Karnataka, India
View Trial DetailsNCT04896476
Arteriovenous Fistula, Arteriovenous Malformations
Dothan, Alabama, United States
View Trial Details